Biomarker-guided Intervention to Prevent Acute Kidney Injury after Major Surgery

Annals of Surgery

Volumn 267, Issue 6, 2018, Pages 1013-1020

  Göcze, Ivan ^a   Jauch, Dominik ^b   Götz, Markus ^a   Kennedy, Pascal ^a   Jung, Bettina ^a   Zeman, Florian ^a   Gnewuch, Carsten ^a   Graf, Bernhard M ^a   Gnann, Wolfgang ^a   Banas, Bernhard ^a   Bein, Thomas ^a   Schlitt, Hans J ^a   Bergler, Tobias ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

acute kidney injury; biomarker; Kidney Disease Improving Global Outcome recommendation; major surgery

Indexed keywords

CREATININE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 7; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1;

ABDOMINAL SURGERY; ACID BASE BALANCE; ACUTE KIDNEY FAILURE; ADULT; AGED; ALBUMIN LEVEL; ARTICLE; CARE BUNDLE; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FEMALE; FLUID INTAKE; HEART FAILURE; HEMODYNAMICS; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MEAN ARTERIAL PRESSURE; PERFUSION PRESSURE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; URINE VOLUME; ABDOMEN; BLOOD; INTENSIVE CARE; LENGTH OF STAY; METABOLISM; MIDDLE AGED; PROCEDURES; SURGERY; URINE;

ABDOMEN; ACUTE KIDNEY INJURY; AGED; BIOMARKERS; CREATININE; CRITICAL CARE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT CARE BUNDLES; PROSPECTIVE STUDIES; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 85047990187     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000002485     Document Type: Article

References (32)

1. Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261: 1207-1214.
2. Long TE, Helgason D, Helgadottir S, et al. Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg. 2016;122:1912-1920.
3. Yi Q, Li K, Jian Z, et al. Risk factors for acute kidney injury after cardiovascular surgery: evidence from 2,157 cases and 49,777 controlsa metaanalysis. Cardiorenal Med. 2016;6:237-250.
4. O'Connor ME, Kirwan CJ, Pearse RM, et al. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med. 2016;42:521-530.
5. Lagny MG, Jouret F, Koch JN, et al. Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the RIFLE classification. BMC Nephrol. 2015;16:76.
6. Vaara ST, Pettila V, Reinikainen M, et al. Population-based incidence, mortality and quality of life in critically ill patients treated with renal replacement therapy: a nationwide retrospective cohort study in Finnish intensive care units. Crit Care. 2012;16:R13.
7. Iwagami M, Yasunaga H, Matsui H, et al. Impact of end-stage renal disease on hospital outcomes among patients admitted to intensive care units: a retrospective matched-pair cohort study. Nephrology (Carlton). 2017;22: 617-623.
8. Dasta JF, Kane-Gill SL, Durtschi AJ, et al. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant. 2008;23: 1970-1974.
9. Gocze I, Bergler T, Bossauer E, et al. The challenge of acute kidney injury: cross-sectional study on prevalence and costs in a university intensive care unit. Med Klin Intensivmed Notfmed. 2016;111:501-507.
10. Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444-2453.
11. Glatz T, Kulemann B, Marjanovic G, et al. Postoperative fluid overload is a risk factor for adverse surgical outcome in patients undergoing esophagectomy for esophageal cancer: a retrospective study in 335 patients. BMC Surg. 2017;17:6.
12. Healy MA, McCahill LE, Chung M, et al. Intraoperative fluid resuscitation strategies in pancreatectomy: results from 38 hospitals in Michigan. Ann Surg Oncol. 2016;23:3047-3055.
13. Schol PB, Terink IM, Lance MD, et al. Liberal or restrictive fluid management during elective surgery: a systematic review and meta-analysis. J Clin Anesth. 2016;35:26-39.
14. Schmid S, Kapfer B, Heim M, et al. Algorithm guided goal-directed haemodynamic therapy does not improve renal function after major abdominal surgery compared to good standard clinical carea prospective randomised trial. Crit Care. 2016;20:50.
15. Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25.
16. Gocze I, Koch M, Renner P, et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS One. 2015; 10:e0120863.
17. Yang QH, Liu DW, Long Y, et al. Acute renal failure during sepsis: potential role of cell cycle regulation. J Infect. 2009;58:459-464.
18. Raimundo M, Crichton S, Martin JR, et al. Increased fluid administration after early acute kidney injury is associated with less renal recovery. Shock. 2015;44:431-437.
19. Brar SS, Aharonian V, Mansukhani P, et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet. 2014;383:1814-1823.
20. Kellum JA, Lameire N, Aspelin P, et al. KDIGO clinical practice guideline for acute kidney injury 2012. Kidney Int. 2012;2:1-138.
21. Kork F, Balzer F, Spies CD, et al. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology. 2015;123:1301-1311.
22. Balasubramanian G, Al-Aly Z, Moiz A, et al. Early nephrologist involvement in hospital-acquired acute kidney injury: a pilot study. Am J Kidney Dis. 2011;57:228-234.
23. O'Connor ME, Kirvan CJ, Pearse RM, et al. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive care Med. 2016;42:521-530.
24. Gunnerson KJ, Shaw AD, Chawla LS, et al. TIMP2.IGFBP7 biomarker panel accurately predicts injury in high risk surgical patients. J Trauma Acute Care Surg. 2016;80:243-249.
25. Eskesen TG,Wetterslev M, Perner A. Systematic review including re-analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness. Intensive Care Med. 2016;42:324-332.
26. Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40:1795-1815.
27. Hoste EA, Maitland K, Brudney CS, et al., ADQI XII Investigators Group. Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth. 2014;113:740-747.
28. Bihari S, Teubner DJ, Prakash S, et al. Fluid bolus therapy in emergency department patients: indications and physiological changes. Emerg Med Australasia. 2016;28:531-537.
29. Chowdhury AH, Cox EF, Francis ST, et al. A randomized, controlled, doubleblind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256:18-24.
30. Bark BP, Grande PO. Infusion rate and plasma volume expansion of dextran and albumin in the septic guinea pig. Acta Anaesthesiol Scand. 2014;58:44-51.
31. Statkevicius S, Bonnevier J, Bark BP, et al. The importance of albumin infusion rate for plasma volume expansion following major abdominal surgeryAIR: study protocol for a randomised controlled trial. Trials. 2016;17:578.
32. Meersch M, Schmidt C, Hoffmeier A, et al. Prevention of cardiac surgeryassociated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017. DOI 10.1007/s00134-016-4670-3.